{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:09:22Z","timestamp":1773893362154,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria","award":["Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"],"award-info":[{"award-number":["Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00702-025-02922-2","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:08:22Z","timestamp":1744366102000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-occurrence of parkinson disease and multiple sclerosis - a critical note"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"2922_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","volume":"123","author":"J Antel","year":"2012","unstructured":"Antel J, Antel S, Caramanos Z, Arnold DL, Kuhlmann T (2012) Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol 123:627\u2013638","journal-title":"Acta Neuropathol"},{"key":"2922_CR2","doi-asserted-by":"publisher","unstructured":"Badri T, Arabfard M, Najafi A, Farnoosh G, Heidari R, Salehi Z, Yaghoob Sehri S, Hassanpour K (2022) Identification of shared molecular signatures between multiple sclerosis and Parkinson\u2019s disease using systems biology approach. Gene Reports 27:101604. https:\/\/doi.org\/10.1016\/j.genrep.2022.101604","DOI":"10.1016\/j.genrep.2022.101604"},{"key":"2922_CR3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.clineuro.2008.03.019","volume":"110","author":"B Barun","year":"2008","unstructured":"Barun B, Brinar VV, Zadro I, Lusic I, Radovic D, Habek M (2008) Parkinsonism and multiple sclerosis - is there association? Clin Neurol Neurosurg 110:958\u2013961","journal-title":"Clin Neurol Neurosurg"},{"key":"2922_CR4","doi-asserted-by":"crossref","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, Parkkinen L, Myllykangas L (2021) Neuropathological evidence of body-first vs. brain-first lewy body disease. Neurobiol Dis 161:105557","journal-title":"Neurobiol Dis"},{"key":"2922_CR5","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1007\/s10072-015-2308-9","volume":"36","author":"A Bougea","year":"2015","unstructured":"Bougea A, Kapaki E, Paraskevas GP, Kilidireas K, Andreadou E (2015) Multiple sclerosis and Parkinson\u2019s disease: the two faces of neurodegeneration. Report of the first Greek case and review of the literature. Neurol Sci 36:2281\u20132285","journal-title":"Neurol Sci"},{"key":"2922_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2922_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ana.27145","volume":"97","author":"WJ Brownlee","year":"2025","unstructured":"Brownlee WJ, Vidal-Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, Barkhof F, Bollo L, Rovira A, Sastre-Garriga J, Tintore M, Rocca MA, Esposito F, Azzimonti M, Filippi M, Bodini B, Lazzarotto A, Stankoff B, Montalban X, Toosy AT, Thompson AJ, Ciccarelli O (2025) Towards a unified set of diagnostic criteria for multiple sclerosis. Ann Neurol 97:571\u2013582","journal-title":"Ann Neurol"},{"key":"2922_CR8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/gerona\/glaa176","volume":"76","author":"AS Buchman","year":"2021","unstructured":"Buchman AS, Yu L, Oveisgharan S, Farfel JM, Schneider JA, Bennett DA (2021) Person-specific contributions of brain pathologies to progressive parkinsonism in older adults. J Gerontol Biol Sci Med Sci 76:615\u2013621","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"2922_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14:176","journal-title":"Cell Death Dis"},{"key":"2922_CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jnc.16040","volume":"168","author":"A Carmona","year":"2024","unstructured":"Carmona A, Carboni E, Gomes LC, Roudeau S, Maass F, Lenz C, Ortega R, Lingor P (2024) Metal dyshomeostasis in the substantia Nigra of patients with Parkinson\u2019s disease or multiple sclerosis. J Neurochem 168:128\u2013141","journal-title":"J Neurochem"},{"key":"2922_CR11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","volume":"97","author":"BAC Cree","year":"2021","unstructured":"Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, Murphy N, Lassmann H (2021) Secondary progressive multiple sclerosis: new insights. Neurology 97:378\u2013388","journal-title":"Neurology"},{"key":"2922_CR12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/NRL.0b013e318224ed84","volume":"17","author":"J Dam\u00e1sio","year":"2011","unstructured":"Dam\u00e1sio J, Ramos C, Valdemar L, da Silva AM, Magalh\u00e3es M (2011) A coincidental case of young-onset Parkinson disease and multiple sclerosis. Neurologist 17:286\u2013288","journal-title":"Neurologist"},{"key":"2922_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00401-024-02742-w","volume":"147","author":"A de Boer","year":"2024","unstructured":"de Boer A, van den Bosch AMR, Mekkes NJ, Fransen NL, Dagkesamanskaia E, Hoekstra E, Hamann J, Smolders J, Huitinga I, Holtman IR (2024) Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions. Acta Neuropathol 147:90","journal-title":"Acta Neuropathol"},{"key":"2922_CR14","first-page":"100055","volume":"3","author":"S Delalic","year":"2020","unstructured":"Delalic S, Rus T, Horvat Ledinek A, Kojovic M, Georgiev D (2020) Parkinson\u2019s disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation. Clin Park Relat Disord 3:100055","journal-title":"Clin Park Relat Disord"},{"key":"2922_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558","journal-title":"Nat Rev Immunol"},{"key":"2922_CR56","unstructured":"Diaz FA, Pel\u00e1ez SAA, Robinson AMA, Carralero EE, Ugarte MD (2021) Multiple sclerosis and Parkinson's disease. Invest Medicoquir 13: https:\/\/www.medigraphic.com\/cgi-bin\/new\/resumenI.cgi?IDARTICULO=106947"},{"key":"2922_CR16","first-page":"88","volume":"13","author":"M Etemadifar","year":"2014","unstructured":"Etemadifar M, Afshar F, Nasr Z, Kheradmand M (2014) Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature. Iran J Neurol 13:88\u201393","journal-title":"Iran J Neurol"},{"key":"2922_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1186\/s12967-023-04516-6","volume":"21","author":"LY Fan","year":"2023","unstructured":"Fan LY, Yang J, Liu RY, Kong Y, Guo GY, Xu YM (2023) Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis. J Transl Med 21:649","journal-title":"J Transl Med"},{"key":"2922_CR18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/mds.870120643","volume":"12","author":"J Federlein","year":"1997","unstructured":"Federlein J, Postert T, Allgeier A, Hoffmann V, P\u00f6hlau D, Przuntek H (1997) Remitting parkinsonism as a symptom of multiple sclerosis and the associated magnetic resonance imaging findings. Mov Disord 12:1090\u20131091","journal-title":"Mov Disord"},{"key":"2922_CR19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.10317","volume":"18","author":"S Folgar","year":"2003","unstructured":"Folgar S, Gatto EM, Raina G, Micheli F (2003) Parkinsonism as a manifestation of multiple sclerosis. Mov Disord 18:108\u2013110","journal-title":"Mov Disord"},{"key":"2922_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/cjn.2022.34","volume":"50","author":"SL Forrest","year":"2023","unstructured":"Forrest SL, Kovacs GG (2023) Current concepts of mixed pathologies in neurodegenerative diseases. Can J Neurol Sci 50:329\u2013345","journal-title":"Can J Neurol Sci"},{"key":"2922_CR21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5334\/tohm.671","volume":"12","author":"R Ghosh","year":"2022","unstructured":"Ghosh R, Roy D, Dubey S, Das S, Benito-Le\u00f3n J (2022) Movement disorders in multiple sclerosis: an update. Tremor Other Hyperkinet Mov (N Y) 12:14","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2922_CR22","doi-asserted-by":"crossref","first-page":"106000","DOI":"10.1016\/j.parkreldis.2024.106000","volume":"120","author":"N Grotewold","year":"2024","unstructured":"Grotewold N, Albin RL (2024) Update: descriptive epidemiology of Parkinson disease. Parkinsonism Relat Disord 120:106000","journal-title":"Parkinsonism Relat Disord"},{"key":"2922_CR23","doi-asserted-by":"crossref","unstructured":"Jellinger KA (2024) The pathobiology of behavioral changes in multiple system atrophy: an update. Int J Mol Sci 25","DOI":"10.3390\/ijms25137464"},{"key":"2922_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.17116\/jnevro202112107299","volume":"121","author":"EA Katunina","year":"2021","unstructured":"Katunina EA, Boyko OV, Shipilova NN, Kabaeva AR, Boyko AN (2021) [A rare clinical case of comorbidity of early-onset Parkinson\u2019s disease and remitting multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova 121:99\u2013103","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"2922_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, National and sub-national-level estimates and future projections. J Epidemiol Glob Health 15:21","journal-title":"J Epidemiol Glob Health"},{"key":"2922_CR26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s00415-004-0570-5","volume":"251","author":"A Kreisler","year":"2004","unstructured":"Kreisler A, Stankoff B, Ribeiro MJ, Agid Y, Lubetzki C, Fontaine B (2004) Unexpected aggravation of Parkinson\u2019s disease by a mesencephalic multiple sclerosis lesion. J Neurol 251:1526\u20131527","journal-title":"J Neurol"},{"key":"2922_CR27","doi-asserted-by":"crossref","unstructured":"Kwon S, Jung SY, Han KD, Jung JH, Yeo Y, Cho EB, Ahn JH, Shin DW, Min JH (2022) Risk of Parkinson\u2019s disease in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea. J Neurol Neurosurg Psychiatry 93:1209\u20131215","DOI":"10.1136\/jnnp-2022-329389"},{"key":"2922_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000333222","volume":"10","author":"X Li","year":"2012","unstructured":"Li X, Sundquist J, Sundquist K (2012) Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener Dis 10:277\u2013284","journal-title":"Neurodegener Dis"},{"key":"2922_CR29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/NEN.0b013e318196e905","volume":"68","author":"JQ Lu","year":"2009","unstructured":"Lu JQ, Fan Y, Mitha AP, Bell R, Metz L, Moore GR, Yong VW (2009) Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions. J Neuropathol Exp Neurol 68:179\u2013189","journal-title":"J Neuropathol Exp Neurol"},{"key":"2922_CR30","doi-asserted-by":"crossref","first-page":"1498756","DOI":"10.3389\/fnagi.2024.1498756","volume":"16","author":"Y Luo","year":"2025","unstructured":"Luo Y, Qiao L, Li M, Wen X, Zhang W, Li X (2025) Global, regional, National epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the global burden of disease study 2021. Front Aging Neurosci 16:1498756","journal-title":"Front Aging Neurosci"},{"key":"2922_CR31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuro.2019.07.007","volume":"74","author":"L Mezzaroba","year":"2019","unstructured":"Mezzaroba L, Alfieri DF, Colado Sim\u00e3o AN, Vissoci Reiche EM (2019) The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology 74:230\u2013241","journal-title":"Neurotoxicology"},{"key":"2922_CR32","doi-asserted-by":"crossref","first-page":"e08518","DOI":"10.1016\/j.heliyon.2021.e08518","volume":"7","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee S (2021) Immune gene network of neurological diseases: multiple sclerosis (MS), Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD) and Huntington\u2019s disease (HD). Heliyon 7:e08518","journal-title":"Heliyon"},{"key":"2922_CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/ene.12255","volume":"21","author":"NM Nielsen","year":"2014","unstructured":"Nielsen NM, Pasternak B, Stenager E, Koch-Henriksen N, Frisch M (2014) Multiple sclerosis and risk of Parkinson\u2019s disease: a Danish nationwide cohort study. Eur J Neurol 21:107\u2013111","journal-title":"Eur J Neurol"},{"key":"2922_CR34","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1177\/1352458508094883","volume":"14","author":"V Nociti","year":"2008","unstructured":"Nociti V, Bentivoglio AR, Frisullo G, Fasano A, Soleti F, Iorio R, Loria G, Patanella AK, Marti A, Tartaglione T, Tonali PA, Batocchi AP (2008) Movement disorders in multiple sclerosis: causal or coincidental association? Mult Scler 14:1284\u20131287","journal-title":"Mult Scler"},{"key":"2922_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fnins.2020.00577","volume":"14","author":"DM O\u2019Hara","year":"2020","unstructured":"O\u2019Hara DM, Pawar G, Kalia SK, Kalia LV (2020) LRRK2 and alpha-synuclein: distinct or synergistic players in Parkinson\u2019s disease? Front Neurosci 14:577","journal-title":"Front Neurosci"},{"key":"2922_CR36","first-page":"145","volume":"17","author":"V Ozturk","year":"2002","unstructured":"Ozturk V, Idiman E, Sengun IS, Yuksel Z (2002) Multiple sclerosis and parkinsonism: a case report. Funct Neurol 17:145\u2013147","journal-title":"Funct Neurol"},{"key":"2922_CR37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/15257770.2020.1844229","volume":"40","author":"M Patoughi","year":"2021","unstructured":"Patoughi M, Ghafouri-Fard S, Arsang-Jang S, Taheri M (2021) Expression analysis of PINK1 and PINK1-AS in multiple sclerosis patients versus healthy subjects. Nucleosides Nucleotides Nucleic Acids 40:157\u2013165","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2922_CR38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.parkreldis.2012.11.021","volume":"19","author":"E Pedemonte","year":"2013","unstructured":"Pedemonte E, Trabucco E, Cella M, Solaro C (2013) Parkinsonism in multiple sclerosis patients: a casual or causal association? Parkinsonism Relat Disord 19:492\u2013493","journal-title":"Parkinsonism Relat Disord"},{"key":"2922_CR39","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","volume":"73","author":"K Rugbjerg","year":"2009","unstructured":"Rugbjerg K, Friis S, Ritz B, Schernhammer ES, Korbo L, Olsen JH (2009) Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology 73:1462\u20131468","journal-title":"Neurology"},{"key":"2922_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.54101\/ACEN.52022.54103.54110","volume":"16","author":"EA Ruina","year":"2022","unstructured":"Ruina EA, Aleksandrova EA, Parshina EV, Rodygin DN, V.S. Y (2022) Rare co-occurrence of multiple sclerosis and Parkinson\u2019s disease: a case report. Annals Clin Experimental Neurol 16:83\u201391. https:\/\/doi.org\/10.54101\/ACEN.52022.54103.54110","journal-title":"Annals Clin Experimental Neurol"},{"key":"2922_CR41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1352458512445942","volume":"19","author":"A Sadnicka","year":"2013","unstructured":"Sadnicka A, Sheerin UM, Kaplan C, Molloy S, Muraro PA (2013) Primary progressive multiple sclerosis developing in the context of young onset Parkinson\u2019s disease. Mult Scler 19:123\u2013125","journal-title":"Mult Scler"},{"key":"2922_CR42","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jocn.2009.09.026","volume":"17","author":"S Saidha","year":"2010","unstructured":"Saidha S, Mok TH, Butler M, Fanning N, Harrington H (2010) Multiple sclerosis exceptionally presenting as parkinsonism responds to intravenous Methylprednisolone. J Clin Neurosci 17:654\u2013655","journal-title":"J Clin Neurosci"},{"key":"2922_CR43","doi-asserted-by":"crossref","first-page":"103796","DOI":"10.1016\/j.msard.2022.103796","volume":"62","author":"S Sarin","year":"2022","unstructured":"Sarin S, Wang A, Elkasaby M, Abboud H (2022) Parkinsonism in multiple sclerosis patients: A prospective observational study. Mult Scler Relat Disord 62:103796","journal-title":"Mult Scler Relat Disord"},{"key":"2922_CR55","doi-asserted-by":"crossref","unstructured":"Shaygannejad V, Shirmardi M, Dehghani L, Maghzi H (2016) Co-occurrence of multiple sclerosis and Parkinson disease. Adv Biomed Res 5:75","DOI":"10.4103\/2277-9175.180993"},{"key":"2922_CR44","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s10072-023-07201-0","volume":"45","author":"K Shindo","year":"2024","unstructured":"Shindo K, Morishima Y, Hata T, Nakajima S, Ueno Y (2024) Parkinson\u2019 s disease complicated after 12 years from the onset of multiple sclerosis. Neurol Sci 45:1775\u20131778","journal-title":"Neurol Sci"},{"key":"2922_CR45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205","journal-title":"Acta Neuropathol"},{"key":"2922_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/NRL.0000000000000333","volume":"26","author":"G Suarez-Cedeno","year":"2021","unstructured":"Suarez-Cedeno G, Mehanna R (2021) Movement disorders in multiple sclerosis and other demyelinating diseases: a retrospective review from a tertiary academic center. Neurologist 26:161\u2013166","journal-title":"Neurologist"},{"key":"2922_CR47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintor\u00e9 M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"2922_CR48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.msard.2016.10.008","volume":"10","author":"A Thormann","year":"2016","unstructured":"Thormann A, Koch-Henriksen N, Laursen B, S\u00f8rensen PS, Magyari M (2016) Inverse comorbidity in multiple sclerosis: findings in a complete nationwide cohort. Mult Scler Relat Disord 10:181\u2013186","journal-title":"Mult Scler Relat Disord"},{"key":"2922_CR49","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/mds.21642","volume":"22","author":"P Valkovic","year":"2007","unstructured":"Valkovic P, Krastev G, Mako M, Leitner P, Gasser T (2007) A unique case of coincidence of early onset Parkinson\u2019s disease and multiple sclerosis. Mov Disord 22:2278\u20132281","journal-title":"Mov Disord"},{"key":"2922_CR50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.freeradbiomed.2010.11.033","volume":"50","author":"MM Wilhelmus","year":"2011","unstructured":"Wilhelmus MM, van der Pol SM, Jansen Q, Witte ME, van der Valk P, Rozemuller AJ, Drukarch B, de Vries HE, Van Horssen J (2011) Association of Parkinson disease-related protein PINK1 with alzheimer disease and multiple sclerosis brain lesions. Free Radic Biol Med 50:469\u2013476","journal-title":"Free Radic Biol Med"},{"key":"2922_CR51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1471-4159.2011.07536.x","volume":"120","author":"R Williams","year":"2012","unstructured":"Williams R, Buchheit CL, Berman NE, LeVine SM (2012) Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 120:7\u201325","journal-title":"J Neurochem"},{"key":"2922_CR52","doi-asserted-by":"crossref","first-page":"1450654","DOI":"10.3389\/fneur.2024.1450654","volume":"15","author":"A Wise","year":"2024","unstructured":"Wise A, Ortega RA, Raymond D, Cervera A, Thorn E, Leaver K, Russell DS, Bressman SB, Crary JF, Saunders-Pullman R (2024) Multiple sclerosis in LRRK2 G2019S Parkinson\u2019s disease and isolated nigral degeneration in a homozygous variant carrier. Front Neurol 15:1450654","journal-title":"Front Neurol"},{"key":"2922_CR53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2017.08.013","volume":"44","author":"M Xuan","year":"2017","unstructured":"Xuan M, Guan X, Gu Q, Shen Z, Yu X, Qiu T, Luo X, Song R, Jiaerken Y, Xu X, Huang P, Luo W, Zhang M (2017) Different iron deposition patterns in early- and middle-late-onset Parkinson\u2019s disease. Parkinsonism Relat Disord 44:23\u201327","journal-title":"Parkinsonism Relat Disord"},{"key":"2922_CR54","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","volume":"5","author":"J Zhu","year":"2024","unstructured":"Zhu J, Cui Y, Zhang J, Yan R, Su D, Zhao D, Wang A, Feng T (2024) Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev 5:e464\u2013e479","journal-title":"Lancet Healthy Longev"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02922-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:34:17Z","timestamp":1769092457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02922-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2922"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02922-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}